Cytokinetics Announces Non-Clinical Data Relating To GSK-923295 Presented At The 32nd

[News]

Cytokinetics, Incorporated (NASDAQ: CYTK) announced that an abstract summarizing non-clinical data relating to GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), was presented as a poster at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center, San Antonio, Texas...

More... (http://www.medicalnewstoday.com/articles/173914.php)